The use of continuous glucose monitoring has created new glucose metrics for both people with diabetes and healthcare professionals to incorporate into diabetes management. While A1C is an average, time in range (TIR) captures when glucose is in the target range (70 mg/dL-180 mg/dL for most individuals), as well as when glucose is above range and below range, providing critical information for treatment decisions as well as health behavior changes. Time in range discussions can lead to more productive diabetes conversations when incorporating strength-based language principles and can lead to discovery learning.
This webinar will review CGM metrics and key principles for educating people with diabetes about TIR goals and opportunities to increase time in range. We’ll share specific features of real-time CGM that may help people move towards more TIR and less time below range. Finally, we’ll present a case study using TIR metrics to incorporate shared decision-making to modify the treatment plan.
This webinar is sponsored by Dexcom. This webinar is FREE for ADCES members and non-members.
Dexcom, Dexcom G6, Dexcom Share, and Dexcom CLARITY are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
- Describe the Consensus Guidelines for time in range measurement and goals for most people with type 1 and type 2 diabetes.
- List 3 features of real-time continuous glucose monitoring that may help people increase time in range.
- Compare the benefits of time in range and CGM metrics in making treatment decisions compared to A1C and blood glucose meter data.